Depression rose threefold among US citizens at start of Covid-19 pandemic
Depression among US citizens has registered a threefold rise due to a sudden economic fallout at the start of Covid-19 pandemic, according.
Drugs
Health
Pharma
Drugs
Health
Pharma
Cambridge scientists develop repurposed liver drug to combat Covid-19
An off-patent drug used to treat lung disease has been identified by scientists at the University of Cambridge as a potential medicine to fight the.
Drugs
Pharma
Pfizer to invest $1.26 billion in Belgium plant in European expansion plan
Pfizer Inc. plans to invest 1.2 billion euros (($1.26 billion) in its plant in Belgium over the next three years to expand in.
Drugs
Health
Pharma
India’s drug regulator gives nod for world’s first nasal Covid-19 vaccine
India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.
Medical
Slowing global economies put post-pandemic recovery at risk: ILO
A slowdown in economic growth and a severe inflationary crisis has affected global pay packets and is putting the post-pandemic recovery at risk,.
Drugs
Health
Medical
Covid-19 disrupts measles dose plan of 40 million children
Forty million children in 2021 have missed their measles vaccination since the beginning of the Covid-19 outbreak, which disrupted the dose schedules, according.
Drugs
Health
Medical
WHO sets up team to hunt down ‘Disease X’
The WHO is preparing for an unknown “Disease X” epidemic by convening more than 300 global scientists to draw evidence from more than.
Drugs
Medical
Pharma
Swedish researchers find possible biomarker for Covid-19
Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.
Drugs
Health
Uncategorized
Covid-19 can reactivate several latent viruses, says Swedish study
Mild Covid can reactivate latent viruses, especially in people suffering from chronic fatigue syndrome
Drugs
Health
Pharma
Global vaccine market remains ‘highly concentrated’
Global vaccine distribution has been inequitable, and vaccines that have been prioritised by the WHO does not see the light of the day,.